Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy

Radiotherapy and Oncology

Volumn 103, Issue 3, 2012, Pages 314-321

  Levitchi, Mihai ^a,b   Charra Brunaud, Claire ^a   Quetin, Philippe ^c   Haie Meder, Christine ^d   Kerr, Christine ^e   Castelain, Bernard ^f   Delannes, Martine ^g   Thomas, Laurence ^h   Desandes, Emmanuel ^a   Peiffert, Didier ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Bon Secours Hospital   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e CENTRE VAL D AURELLE   (France)

^f CENTRE OSCAR LAMBRET   (France)

^g INSTITUT CLAUDIUS REGAUD   (France)

^h INSTITUT BERGONIÉ   (France)

Author keywords

Cervical cancer; Dose volume histogram; Image guided brachytherapy; Organs at risk; Pulsed dose rate brachytherapy; Side effects

Indexed keywords

ADULT; AGE; ARTERITIS; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PELVIS SURGERY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM; SCORING SYSTEM; SMOKING; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; BRACHYTHERAPY; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MIDDLE AGED; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY TRACT; UTERINE CERVICAL NEOPLASMS;

EID: 84861812646     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.04.008     Document Type: Article

References (56)

1. A. Gerbaulet, R. Pötter, and C. Haie-Meder Cervix cancer A. Gerbaulet, R. Pötter, C. Haie-Meder, GEC ESTRO handbook of brachytherapy 2002 ESTRO Brussels 301 363
2. S. Nag, B. Erickson, B. Thomadsen, C. Orton, J.D. Demanes, and D. Petereit The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 48 2000 201 211
3. D.J. Brenner, and E.J. Hall Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy Int J Radiat Oncol Biol Phys 20 1991 181 190
4. T. Veninga, A.G. Visser, A.P. van den Berg, C.M. van Hooije, C.A. van Geel, and P.C. Levendag Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation Int J Radiat Oncol Biol Phys 49 2001 1351 1360
5. D.J. Brenner, P.B. Schiff, Y. Huang, and E.J. Hall Pulsed-dose-rate brachytherapy: design of convenient (daytime-only) schedules Int J Radiat Oncol Biol Phys 39 1997 809 815
6. P.S. Swift, P. Purser, L.W. Roberts, B. Pickett, C.B. Powell, and T.L. Phillips Pulsed low dose rate brachytherapy for pelvic malignancies Int J Radiat Oncol Biol Phys 37 1997 811 817
7. L. Rogers, J.H. Freel, and L.B. Speiser Pulsed-dose-rate brachytherapy for uterine cervix carcinoma Int J Radiat Oncol Biol Phys 43 1999 95 100
8. B. Bachtiary, A. Dewitt, and M. Pintilie Comparison of late toxicity between, continuous low dose rate and pulsed-dose-rate brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 63 2005 1077 1082
9. S. Chargari, N. Magne, and I. Dumas Physics contributions and clinical outcome with 3D-MRI based PDR intracavitary brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 74 2009 133 139
10. G. Rath, D.N. Sharma, P.K. Julka, V. Subramani, A.l. Bah, and K.P. Haresh Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma the aims experience Am J Clin Oncol 33 2010 238 241
11. I. Barillot, J.C. Horiot, and P. Maingon Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies Int J Radiat Oncol Biol Phys 48 2000 189 200
12. S.W. Chen, J.A. Liang, S.N. Yang, R.T. Lui, and F.J. Lin The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 47 2000 955 961
13. P.J. Eifel, W.W. Thoms Jr., T.L. Smith, M. Morris, and M.J. Oswald The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone Int J Radiat Oncol Biol Phys 28 1994 113 118
14. P.J. Eifel, C. Levenback, T. Wharton, and M.J. Oswald Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage Ib carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 32 1995 1289 1300
15. T.H. Hyun Kim, J. Choi, and S.Y. Park Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma Cancer 104 2005 1304 1311
16. C.A. Perez, P.E. Grigsby, M.A. Lockett, K.S. Chao, and J. Williamson Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation Int J Radiat Oncol Biol Phys 44 1999 855 856
17. K.I. Sakata, H. Nagakura, and A. Oouchi High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications Int J Radiat Oncol Biol Phys 54 2002 1369 1376
18. C.J. Wang, S.W. Leung, and H.C. Chen High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme Int J Rad Oncol Biol Phys 38 1997 391 398
19. P. Georg, C. Kirisits, and G. Goldner Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy Radiother Oncol 91 2009 173 180
20. B.G. Clark, L. Souhami, T.N. Roman, R. Chappell, M.D. Evans, and J.F. Fowler The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 38 1997 989 993
21. ICRU International Commission on Radiation Units and Measurements. ICRU report 38: dose and volume specification for reporting intracavitary therapy in gynaecology 1985 ICRU Bethesda
22. M. De Brabandere, A.G. Mousa, A. Nulens, A. Swinnen, and E. van Limbergen Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma Radiother Oncol 88 2008 217 226
23. R.Y. Kim, and P. Pareek Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms Brachytherapy 2 2003 200
24. J.C. Lindegaard, K. Tanderup, S.K. Nielsen, S. Haack, and J. Gelineck MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 71 2008 756 764
25. S. Nag, H. Cardenes, and S. Chang Proposed quidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group Int J Radiat Oncol Biol Phys 60 2004 1160 1172
26. A.M. Olszewska, A.E. Saarnak, R.W. de Boer, B.N. van Bunningen, and M.J. Steggerda Comparison of dose-volume histograms and dose-wall histograms of the rectum of patients treated with intracavitary brachytherapy Radiother Oncol 61 2001 83 85
27. R. Pötter, J. Dimopoulos, and B. Bachtiary 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up Radiother Oncol 79 2006 80 86
28. R. Pötter, J. Dimopoulos, and P. Georg Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155
29. C. Haie-Meder, R. Pötter, and E. van Limbergen Recommendations from the Gynaecological (GYN) GEC ESTRO Working Group: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245
30. R. Pötter, C. Haie-Meder, and E. van Limbergen Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
31. K. Tanderup, S.K. Nielsen, and G.B. Nyvang From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Radiother Oncol 94 2010 173 178
32. W.S. Koom, D.Y. Sohn, and J.Y. Kim Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy Int J Radiat Oncol Biol Phys 68 2007 1446 1454
33. H.C. Kang, K.H. Shin, S.-Y. Park, and J.-Y. Kim 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control Radiother Oncol 97 2010 507 513
34. P. Georg, S. Lang, and J. Dimopoulos Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy Int J Radiat Oncol Biol Phys 79 2011 356 362
35. E.F. Fidarova, D. Berger, and S. Schüssler Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses Radiother Oncol 97 2010 76 79
36. C. Charra-Brunaud, and D. Peiffert Preliminary results of a French prospective-multicentric study of 3D pulsed dose-rate brachytherapy for cervix carcinoma Cancer Radiother 12 2008 527 531
37. R.G. Dale The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy Br J Radiol 58 1985 515 552
38. R.G. Dale The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions and possible implications for treatments involving multiple fractions per day Br J Radiol 59 1986 919 927
39. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
40. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
41. D.R. Cox Regression model and lifer tables (with discussion) J R Stat Soc B 34 1972 187 220
42. Georg P, Pötter R, Georg D, et al. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image guided adaptative cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys. http://dx.doi.org/10.1016/j.ijrobp.2010.12.029.
43. I. Barillot, J.C. Horiot, P. Maingon, M.C. Bone-Lepinoy, D. Vaillant, and S. Feutray Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy Radiother Oncol 30 1994 231 238
44. C. Fellner, R. Potter, T.H. Knocke, and A. Wambersie Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects Radiother Oncol 58 2001 53 62
45. K.H. Shin, T.H. Kim, and J.K. Cho CT guided intracavitary radiotherapy for cervical cancer: comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters Int J Radiat Oncol Biol Phys 64 2006 197 204
46. A.A.C. De Leeuw, J.B. Van de Kamer, M.A. Moerland, M.E.P. Philippens, and I.M. Jürgenliemk-Schulz The effect of alternative biological modelling parameters (α/β and half time of repair T) on reported EQD2 values in the treatment of advanced cervical cancer Radiother Oncol 101 2011 337 342
47. S. Lang, C. Kirisits, J. Dimopoulos, D. Georg, and R. Pötter Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints Int J Radiat Oncol Biol Phys 69 2007 619 627
48. H.J. Kim, S. Kim, S.W. Ha, and H.G. Wu Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer? Tumori 94 2008 327 332
49. G. Sinistrero, P. Sismondi, A. Rumore, and P. Zola Analysis of complications of cervix carcinoma treated by radiotherapy using the Franco-Italian glossary Int J Radiat Oncol Biol Phys 26 1993 203 211
50. C. Haie-Meder, C. Chargari, A. Rey, I. Dumas, P. Morice, and N. Magné DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery Radiother Oncol 93 2009 316 321
51. H. Kucera, H. Enzelsberger, and W. Eppel The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix Cancer 60 1987 1 4
52. P.J. Eifel, A. Jhingran, D.C. Bodurka, C. Levenback, and H. Thames Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer J Clin Oncol. 20 2002 3651 3657
53. M. Cengiz, S. Gürdalli, and U. Selek Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three dimensional computed tomography plan evaluation Int J Radiat Oncol Biol Phys 70 2008 464 466
54. D. Bodurka-Bevers, M. Morris, and P.J. Eifel Post therapy surveillance of women with cervical cancer: an outcomes analysis Gynecol Oncol 78 2000 187 193
55. N. Wachter-Gerstner, S. Wachter, and E. Reinstadler Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point Radiother Oncol 68 2003 269 276
56. A.N. Viswanathan, J. Dimopoulos, C. Kirisits, D. Berger, and R. Pötter Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours Int J Radiat Oncol Biol Phys 68 2007 491 498